Stifel Financial’s HTG Molecular Diagnostics HTGM Stock Holding History
Bought
Maintained
Sold
Other funds holding HTGM
Stifel Financial's HTGM Position: Q3 2019 in Review
Stifel Financial sold out of HTG Molecular Diagnostics (HTGM) in Q3 2019, closing a stake of 318 shares — an estimated $96K sold.
Stifel Financial first reported a position in HTGM in Q1 2018 and held it in 6 quarters. The position peaked at $1.01M in Q3 2018. 44 funds tracked by Wall St. Rank hold HTGM as of Q3 2019.
- Stifel Financial reported no remaining HTG Molecular Diagnostics position as of Q3 2019 after selling out during the quarter.
- Stifel Financial sold 318 HTG Molecular Diagnostics shares in Q3 2019, an estimated $96K.
- Stifel Financial first reported a position in HTG Molecular Diagnostics in Q1 2018 and held it in 6 quarters.
- Stifel Financial's HTG Molecular Diagnostics position peaked at $1.01M in Q3 2018.
- 44 funds tracked by Wall St. Rank held HTG Molecular Diagnostics as of Q3 2019.
Based on Stifel Financial's 13F filing for Q3 2019, filed 13 Nov 2019.